Both in Pharmaceuticals
Ernexa Therapeutics vs Aptevo Therapeutics
Over the past year ERNA returned −95.6% and APVO returned −94.7%; their daily moves had a correlation of -0.06.
ERNA −95.6% APVO −94.7%Growth of $1, one year, split-adjusted
| Metric | ERNA | APVO |
|---|---|---|
| Price | $1.97 | $1.34 |
| Market cap | $2.3M | $2.4M |
| Today | −6.64% | −1.47% |
| 1 month | −33.4% | −23.9% |
| 6 months | −97.9% | −72.8% |
| Year to date | −93.4% | −85.8% |
| 1 year | −95.5% | −94.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 79.7% | 112.9% |
| Short % of float | 2.1% | 5.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).